519 filings
Page 6 of 26
8-K
wgkr3q767vpht6
15 May 19
Submission of Matters to a Vote of Security Holders
4:10pm
424B5
1coddddpcfn o42luu6
7 May 19
Prospectus supplement for primary offering
8:31am
8-K
cfq9spv2yp2ta ubx5
7 May 19
MannKind Corporation Reports 2019 First Quarter Financial Results
8:00am
EFFECT
3snom50chqc
8 Apr 19
Notice of effectiveness
12:15am
UPLOAD
0a0jv4a49q d6gq032
4 Apr 19
Letter from SEC
12:00am
CORRESP
oknkqf oh
3 Apr 19
Correspondence with SEC
12:00am
DEFA14A
z6cva36ate46i1rjosb
28 Mar 19
Additional proxy soliciting materials
4:13pm
8-K
3a4u4d 9goa00ccpu60h
26 Feb 19
MannKind Corporation Fourth Quarter and Year-End 2018 Earnings Call
8:05am
8-K
mwcabqg6
21 Dec 18
MannKind Announces Commencement of Public Offering
12:00am
424B5
wi61xg3z
21 Dec 18
Prospectus supplement for primary offering
12:00am
424B5
o48z6cdc
19 Dec 18
Prospectus supplement for primary offering
4:10pm
8-K
kjzoqwg9ecsd8m7v6ywk
3 Dec 18
MannKind Appoints Christine Mundkur to its Board of Directors
4:05pm
CT ORDER
u21zcfoqb0yi3m7u2l
30 Nov 18
Confidential treatment order
11:12am
8-K
p45v8yvd
1 Nov 18
MannKind Corporation Reports 2018 Third Quarter Financial Results
8:05am
8-K
20m3ehukkm
16 Oct 18
United Therapeutics and Mannkind Announce Closing
4:58pm